바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기


진료과

  • 의과대학-산부인과학교실, 산부인과, 자궁·난소암센터

전문진료분야

  • <산부인과> 부인암 (자궁암, 난소암)

진료시간표

인터넷진료예약
의사시간표
진료시간
오전 통상진료 통상진료
오후 통상진료 통상진료

교육 및 임상 경력

  • 1999    -    2004    가톨릭대학교    의과대학    산부인과학교실    조교수 
  • 2000    -    2003    Harvard  Medical  School  Brigham  and  Women’s  Hospital 
  • 2004    -    2010    연세대학교    의과대학    산부인과학교실  부교수 
  • 2008    -    2016      연세대학교    강남세브란스병원    산부인과  과장   
  • 2010    -    현재      연세대학교    의과대학  산부인과학교실  교수 
  • 2010    -    현재      연세대학교    강남세브란스병원    부인암  클리닉  팀장
  • 2011    -    현재      의과대학  강남부학장  강남의학연구센터  소장
  • 2012    -    현재      한국  부인암은행(KGCB)    은행장

학술관련경력

  • 대한산부인과학회정회원 및 간사, 대한부인종양연구회,
  • 대한부인종양콜포스코피학회 사무총장

주요 관심분야

  • 부인종양학 (임상시험 및 이행성연구)

학력사항

  • 가톨릭대학교 의과대학 졸업 의학사(1989)
  • 가톨릭대학교 의과대학원 졸업 의학석사(1993)
  • 가톨릭대학교 의과대학원 졸업 의학박사(1998)

논문

  • High glucose-induced intracellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-xB-dependent
    DIABETOLOGIA 43/12 :1533-1544,2000
  • The utility of Mmatrix metalloproteinase-2 as a tumor marker in cervical cancer
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 44/1 :121-127,2001
  • Human Seminal Plasma Kills Human Epithelial Ovarian Cancer Cells via Induction of Necrosis
    대한부인종양,콜포스코피학회 13/3 :219-227,2002
  • Osteopontin as apotential diagnostic biomarker for ovarian cancer
    JAMA 287/13 :1671-1679,2002
  • Osteopontin is down-regulated in hydatidiform mole
    GYNECOLOGIC ONCOLOGY 89/0 :134-139,2003
  • Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer
    CLINICAL CANCER RESEARCH 9/13 :4782-4791,2003
  • New approaches to functional process discovery in HPV 16-associated cervical cancer cells by gene ontology
    암연구와치료 35/4 :304-313,2003
  • 원발성 복막암의 임상적 고찰
    대부종콜포회지 15/2 :107-112,2004
  • 인두유종 바이러스와 관련한 크라미디아 트라코마티스 감염에 대한 임상적 고찰
    대한산부회지 47/4 :670-677,2004
  • 인유두종 바이러스의 발암성 단백질의 발현을 저해하는 Trans Attack 항암성 유전자 백신의 개발
    대한산부회지 47/2 :258-263,2004
  • 임신 29주에서 자궁선근증과 동반된 자궁각 임신의 자궁파열 1예
    대한산부회지 47/6 :1228-1231,2004
  • 자궁경부암의 위험 인자로서 환자의 비만도에 대한 분석
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 47/12 :-,2004
  • 태아성장에 있어 제대혈액과 모체혈액 랩틴
    대한산부회지 47/1 :5-9,2004
  • An Analysis of the Risk Factors and Management of Lymphocele after Pelvic Lymphadenectomy in Patients with Gynecologic Malignancies
    CANCER RESEARCH AND TREATMENT 36/6 :377-383,2004
  • Clinical usefulness of cervicogram as a primary screening test for cervical neoplasia
    YONSEI MEDICAL JOURNAL 46/2 :213-220,2005
  • 산발성 난소암에서의 BRCA1과 BRCA2의 배선 유전자 돌연변이와 유전자다형성
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 48/6 :1466-1475,2005
  • Prognostic significance of DNA quantification by flow cytometry in ovarian tumors
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS 88/3 :286-291,2005
  • The influence of time intervals between loop electrosurgical excision and subsequent hysterectomy on the morbidity of patients with cervical neoplasia
    GYNECOLOGIC ONCOLOGY 96/2 :500-503,2005
  • 동시 항암화학방사선 지료를 받은 자궁경부암 환자에서 squamous cell carcinoma antigen과 예후와의 상관관계
    부인종양(Korean Journal Of Gynecologic Oncology) 16/2 :123-132,2005
  • 항암화학요법을 시행받은 부인암 환자에서 recombinant human erythropoietin의 임상적 유용성
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 48/1 :80-87,2005
  • Pretreatment levels of serum squamous cell carcinoma antigen and urine polyamines in women with squamous cell carcinoma of the cervix
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS 91/ :47-52,2005
  • Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma
    GYNECOLOGIC ONCOLOGY 99/ :585-590,2005
  • 혈청 CA-125, 초음파 및 양전자방출단층촬영술을통한 골반 종물의 감별진단
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 48/8 :1926-1933,2005
  • 침윤성 자궁경부암에서 실시간 정량 역전사 중합효소 연쇄 반응을 이용한 cyclin B1과 D1의 발현
    부인종양(Korean Journal Of Gynecologic Oncology) 16/3 :256-263,2005
  • 새로운 악성 Brenner 종양 세포주 확립
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 48/10 :2321-2329,2005
  • 난소암에서 cyclin B1 및 D1 발현과임상 예후 인자들과의 관련성
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 48/11 :2670-2681,2005
  • 난소암 조직에서 HLA-G유전자 발현과예후 인자와의 상관성
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 48/12 :2910-2918,2005
  • Conventional Papanicolaou smear, fluid-based thin-layer method와 cervicography의 비교 분석
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 48/12 :2932-2940,2005
  • 동시 항암화학방사선요법을 시행 받은 자궁경부암 환자에서 빈혈이 예후에 미치는 영향
    대한피부과학회지 48/1 :73-79,2005
  • 종양특이 cDNA microarray를 이용한 상피성 난소암에서의 유전자 발현 변화
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 48/7 :1708-1721,2005
  • Expression profiling of cyclin B1 and D1 in cervical carcinoma
    EXPERIMENTAL ONCOLOGY 28/1 :44-48,2006
  • 다발성으로 전이된 저등급 자궁내막 간질성 육종 1예
    대한산부인과학회지(KOREAN JOURNAL OF OBSTETRICS AND GYNECOLOLY) 49/9 :1993-1998,2006
  • 외음부 파젯씨병
    대한산부인과학회지(KOREAN JOURNAL OF OBSTETRICS AND GYNECOLOLY) 49/8 :1667-1673,2006
  • 난소에 발생한 간양 암종 1예
    대한부인종양,콜포스코피학회 17,1/ :84-88,2006
  • 난소 기형종에서 혈청 CA19-9의 임상적 유용성
    대한산부인과학회지(KOREAN JOURNAL OF OBSTETRICS AND GYNECOLOLY) 49/9 :1876-1880,2006
  • 난소의 성숙낭성기형종에서 기원한 편평상피세포암의 임상병리학적 고찰
    대한산부인과학회지(KOREAN JOURNAL OF OBSTETRICS AND GYNECOLOLY) 49/7 :1455-1462,2006
  • 자궁경부 상피내종양에서 p16ink4a와 pRb의 이상 발현과 고위험 군 인유두종바이러스 감염 및 재발의 상관성에 관한 연구
    대한산부인과학회지(KOREAN JOURNAL OF OBSTETRICS AND GYNECOLOLY) 49/7 :1437-1445,2006
  • 자궁내막암 환자에서 유세포 분석을 통한 핵 DNA 정량검사와 임상병리학 예후 인자와의 상관성
    대한산부인과학회지(KOREAN JOURNAL OF OBSTETRICS AND GYNECOLOLY) 49/3 :620-627,2006
  • Prognostic factors and expression of p53 and mdm-2 in uterine sarcomas
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS 95/ :272-277,2006
  • 임신과 동반된 난소 섬유육종 1예
    대한산부인과학회지(KOREAN JOURNAL OF OBSTETRICS AND GYNECOLOLY) 49/11 :2404-2409,2006
  • 자궁경부암에서 Cdc25A, Cdc25B 및 Cdc25C의 발현
    대한산부인과학회지(KOREAN JOURNAL OF OBSTETRICS AND GYNECOLOLY) 49/10 :2156-2165,2006
  • 로봇 복강경하 전자궁절제술: 한국최초 임상보고
    대한산부인과학회지(KOREAN JOURNAL OF OBSTETRICS AND GYNECOLOLY) 49/12 :2620-2625,2006
  • Microarray comparative genomic hybridization을 이용한 진행된 장액성 난소암의 염색체 변화 분석
    부인종양(Korean Journal Of Gynecologic Oncology) 17/4 :294-301,2006
  • Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy
    GYNECOLOGIC ONCOLOGY 105/ :199-204,2007
  • An ovarian steroid cell tumor causing virilization and massive ascites
    YONSEI MEDICAL JOURNAL 48/1 :142-146,2007
  • Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease
    GENES CHROMOSOMES & CANCER 46/ :1-9,2007
  • 자궁경부암에서 HLA-G와 IL-10의 발현 및 상호작용
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 50/1 :126-134,2007
  • 외음부 암의 생존율 예측인자: 인유두종 바이러스와의 연관성
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 50/9 :1233-1239,2007
  • The expressions of the Rb pathway in cervical intraepithelial neoplasia; predictive and prognostic significance
    GYNECOLOGIC ONCOLOGY 104/ :207-211,2007
  • Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS 98/ :48-53,2007
  • Evaluation of serum and urinary angiogenic factors in patients with endometriosis
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 58/ :497-504,2007
  • 자궁경부암에서 3차원 자기공명영상 디지털자료의 컴퓨터 가상기법을 이용한 예후인자의 개발
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 50/10 :1363-1370,2007
  • 폐 전이를 동반한 재발성 자궁경부암 환자의 예후인자
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 50/6 :887-892,2007
  • A case of placenta increta presenting as delayed postabortal intraperitoneal bleeding in the first trimester
    JOURNAL OF KOREAN MEDICAL SCIENCE 22/5 :932-935,2007
  • Efficacy of different types of treatment in FIGO stage IB2 cervical cancer in Korea: Results of a multicenter retrospective Korean study (KGOG-1005)
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 17/ :132-136,2007
  • 요천추 신경근으로 전이된 재발성 자궁경부암 1예
    대한산부인과학회지(Korean Journal of Obstetrics and Gynecololy) 50/11 :1547-1551,2007
  • 영동세브란스병원 주산기 사망 1998-2003
    대한주산의학회잡지(THE KOREAN JOURNAL OF PERINATOLOGY) 19/1 :11-17,2008
  • MicroRNA expression profiles in serous ovarian carcinoma
    Clinical Cancer Research 14/ :2690-2695,2008
  • Platinum 제제가 포함된 항암화학요법을 받은 부인암 환자에서의 당뇨병 발생 위험
    대한산부인과학회지(Korean Journal Of Obstetrics And Gynecology) 51/2 :167-172,2008
  • Clinical approach and surgical strategy for spinal diseases in pregnant women - A report of ten cases
    Spine 33/17 :E614-E619,2008
  • Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma
    European Journal Of Obstetrics Gynecology And Reproductive Biology 136/ :110-115,2008
  • Endometrial Stromal Sarcomas: A Retrospective Analysis of 28 Patients, Single Center Experience for 20 Years
    Cancer Research And Treatment 40/1 :6-10,2008
  • Expression of the p16INK4a and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection
    Journal Of Gynecologic Oncology 19/3 :162-168,2008
  • Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients
    Clinical Cancer Research 14/ :764-771,2008
  • Development and validation of a nomogram for predicting outcome of patients with vulvar cancer
    Journal Of Gynecologic Oncology / :-,2008
  • Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line
    MOLECULAR AND CELLULAR BIOCHEMISTRY 319/1-2 :189-201,2008
  • 소세포 폐암에서 전이된 전이성 난소암 1예
    대한산부인과학회지(Korean Journal Of Obstetrics And Gynecology) 51/11 :1356-1361,2008
  • Clinical significance of osteopontin expression in cervical cancer
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 134/ :909-917,2008
  • Clinical significance of microsatellite instability in sporadic epithelial ovarian tumors
    Yonsei Medical Journal 49/ :272-278,2008
  • 자궁내막암 환자에서 엽산, 비타민 B12의 섭취량 및 혈청 측정을 통한 자궁내막암 발생위험도 분석: 환자 대조군 연구
    대한산부인과학회지(Korean Journal Of Obstetrics And Gynecology) 51/10 :1103-1111,2008
  • Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
    Cancer Immunology Immunotherapy 58/ :15-23,2009
  • Endometrial Osteopontin mRNA Expression and Plasma Osteopontin Levels are Increased in Patients with Endometriosis
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 61/ :286-293,2009
  • Molecular characterization of a new ovarian cancer cell line, YDOV-151, established from mucinous cystadenocarcinoma
    Tohoku Journal Of Experimental Medicine 218/2 :129-139,2009
  • Expression of interleukin-5 and tumor necrosis factor alpha in cervical carcinoma
    Clinical And Vaccine Immunology 16/6 :959-961,2009
  • Diagnostic and Prognostic Impact of Osteopontin Expression in Endometrial Cancer
    CANCER INVESTIGATION 27/ :313-323,2009
  • Acute toxicity of cyclooxygenase-2 inhibitor rofecoxib as a radiosensitizer for concurrent chemoradiation in the treatment of uterine cervical cancer
    Journal Of Gynecologic Oncology 30/3 :151-157,2009
  • Correlation of human leukocyte antigen-g (hla-g) expression and disease progression in epithelial ovarian cancer
    Reproductive Sciences 16/11 :1103-1111,2009
  • Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer.
    Journal Of Histochemistry & Cytochemistry 57/5 :513-521,2009
  • Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer.
    Biomarkers In Medicine 14/3 :161-170,2009
  • Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: A case-control study
    Clinical Chemistry And Laboratory Medicine 47/8 :1005-1012,2009
  • Treatment of the patients with abnormal cervical cytology: a see-and-treat versus three-step strategy
    Journal Of Gynecologic Oncology 20/3 :164-168,2009
  • Surgical practice patterns in endometrial cancer: results of the Korean Gynecologic Oncology Group survey
    Journal Of Gynecologic Oncology 20/ :107-112,2009
  • Comparison of human papillomavirus detection and typing by hybrid capture 2, linear array, DNA chip, and cycle sequencing in cervical swab samples.
    International Journal Of Gynecological Cancer 19/2 :266-272,2009
  • Plasma carotenoids, retinol and tocopherol levels and the risk of ovarian cancer.
    Acta Obstetricia Et Gynecologica Scandinavica 88/4 :457-462,2009
  • Preoperative levels of plasma micronutrients are related to endometrial cancer risk.
    Acta Obstetricia Et Gynecologica Scandinavica 88/4 :434-439,2009
  • Functional polymorphism in manganese superoxide dismutase and antioxidant status: their interactions on the risk of cervical intraepithelial neoplasia and cervical cancer.
    Gynecologic Oncology 115/2 :272-276,2009
  • Robot-Assisted Staging Using Three Robotic Arms for Endometrial Cancer: Comparison to Laparoscopy and Laparotomy at a Single Institution
    Journal Of Surgical Oncology 101/ :116-121,2010
  • Diagnosis and staging of primary ovarian cancer: Correlation between PET/CT, Doppler US, and CT or MRI
    Gynecologic Oncology 116/3 :389-394,2010
  • Prevalence and clinical relevance of cyclooxygenase-1 and -2 expression in stage IIB cervical adenocarcinoma
    European Journal of Obstetrics Gynecology and Reproductive Biology 148/1 :62-66,2010
  • Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy
    Journal Of Gynecologic Oncology 21/1 :18-23,2010
  • Accuracy of preoperative tests in clinical stage I endometrial cancer: the importance of lymphadenectomy
    Acta Obstetricia Et Gynecologica Scandinavica 89/ :175-181,2010
  • Efficacy and Toxicity of Belotecan With and Without Cisplatin in Patients With Recurrent Ovarian Cancer
    American Journal of Clinical Oncology-Cancer Clinical Trials 33/3 :233-237,2010
  • ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139
    International Journal Of Oncology 37/2 :399-412,2010
  • The feasibility of carboplatin-based intraperitoneal chemotherapy in ovarian cancer
    European Journal of Obstetrics Gynecology and Reproductive Biology 152/ :195-199,2010
  • Autoantibodies Against Stress-Induced Phosphoprotein-I as a Novel Biomarker Candidate for Ovarian Cancer
    Genes Chromosomes & Cancer 49/7 :585-595,2010
  • Prevalence and Seroprevalence of High-Risk Human Papillomavirus Infection
    Obstetrics And Gynecology 116/4 :932-940,2010
  • Transumbilical single-port access versus conventional total laparoscopic hysterectomy: surgical outcomes
    American Journal of Obstetrics and Gynecology 203/1 :26.e-1-26.e-6,2010
  • Two-Port Access Staging Laparoscopy for Gynecologic Cancers: A Pilot Study
    JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES 20/4 :347-353,2010
  • Vaccination with a Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Cervical Cancer Vaccine in Korean Girls Aged 10-14 Years
    JOURNAL OF KOREAN MEDICAL SCIENCE 25/8 :1197-1204,2010
  • The feasibility of scarless single-port transumbilical total laparoscopic hysterectomy: initial clinical experience
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 24/7 :1686-1692,2010
  • A case-control study of robotic radical hysterectomy and pelvic lymphadenectomy using 3 robotic arms compared with abdominal radical hysterectomy in cervical cancer.
    International Journal Of Gynecological Cancer 20/7 :1284-1289,2010
  • Epidemiological characteristics of ovarian cancer in Korea
    Journal Of Gynecologic Oncology 21/4 :241-247,2010
  • The effects of polymorphisms in methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), and methionine synthase reductase (MTRR) on the risk of cervical intraepithelial neoplasia and cervical cancer in Korean women
    Cancer Causes & Control 21/ :23-30,2010
  • Comparisons of Surgical Outcomes, Complications, and Costs Between Laparotomy and Laparoscopy in Early-Stage Ovarian Cancer
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 21/2 :251-256,2011
  • Comparison of the Efficacy and Toxicity Between Radiotherapy and Chemotherapy in Nodal and Isolated Nonnodal Recurrence of Ovarian Cancer
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 21/6 :1032-1039,2011
  • Comparative Proteomic Analysis of Advanced Serous Epithelial Ovarian Carcinoma: Possible Predictors of Chemoresistant Disease
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY 15/5 :281-292,2011
  • Robotic single-port transumbilical total hysterectomy: a pilot study
    JOURNAL OF GYNECOLOGIC ONCOLOGY 22/2 :120-126,2011
  • Feasibility and Surgical Outcomes of Laparoscopic Metastasectomy in the Treatment of Ovarian Metastases From Gastric Cancer
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 21/7 :1306-1311,2011
  • 로봇을 이용한 자궁근종절제술의 유용성: 복강경 그리고 개복수술과 비교
    대한산부인과학회지 54/12 :784-793,2011
  • Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: A case-control study
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY 160/1 :100-105,2012
  • Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma
    JOURNAL OF MOLECULAR MEDICINE-JMM 90/ :427-434,2012
  • Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH 38/1 :48-56,2012
  • Prevalence and Seroprevalence of Low-Risk Human Papillomavirus in Korean Women
    JOURNAL OF KOREAN MEDICAL SCIENCE 27/8 :922-928,2012
  • MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line
    BMC MEDICAL GENOMICS 5/1 :18-,2012
  • Nanog signaling in cancer promotes stem-like phenotype and immune evasion
    JOURNAL OF CLINICAL INVESTIGATION 122/11 :4077-4093,2012
  • Prognostic Impact of the Cancer Stem Cell-Related Marker NANOG in Ovarian Serous Carcinoma
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 22/9 :1489-1496,2012
  • Serum HE4 Level is an Independent Prognostic Factor in Epithelial Ovarian Cancer
    ANNALS OF SURGICAL ONCOLOGY 19/5 :1707-1712,2012
  • Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia
    OBSTETRICS AND GYNECOLOGY 121/2 :321-329,2013
  • The ON-Q pain management system in elective gynecology oncologic surgery: Management of postoperative surgical site pain compared to intravenous patient-controlled analgesia
    Obstetrics & Gynecology Science 56/02 :93-101,2013
  • Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition
    JOURNAL OF GYNECOLOGIC ONCOLOGY 24/2 :186-203,2013
  • Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer.
    HUMAN PATHOLOGY 44/7 :1365-1374,2013
  • Chemoradiation with paclitaxel and carboplatin in high-risk cervical cancer patients after radical hysterectomy: a Korean Gynecologic Oncology Group study
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 86/2 :304-310,2013
  • Comparison of carboplatin- and cisplatin-based concurrent chemoradiotherapy in locally advanced cervical cancer patients with morbidity risks
    ONCOLOGIST 18/7 :843-849,2013
  • Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.
    JOURNAL OF TRANSLATIONAL MEDICINE 11/185 :1-11,2013
  • Overexpression of Glucose Transporter-1 (GLUT-1) Predicts Poor Prognosis in Epithelial Ovarian Cancer.
    CANCER INVESTIGATION 31/9 :607-615,2013
  • Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer
    BIOMARKERS 18/7 :573-579,2013
  • Two-Port Access Laparoscopic Surgery in Gynecologic Oncology
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 23/5 :935-942,2013
  • Expression of Stress-Induced Phosphoprotein1 (STIP1) is Associated with Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer
    GENES CHROMOSOMES & CANCER 53/4 :277-288,2014
  • Synaptonemal Complex Protein 3 Is a Prognostic Marker in Cervical Cancer
    PLOS ONE 9/6 :e98712-,2014
  • The role of S100A14 in epithelial ovarian tumors
    ONCOTARGET 5/ :3482-3496,2014
  • Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer
    BMC CANCER 14/545 :1-2,2014
  • A Phase 2 Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy After Surgery in Patients With High-Risk Endometrial Cancer: A Korean Gynecologic Oncologic Group Study
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 90/1 :140-146,2014
  • Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer
    JOURNAL OF CLINICAL ONCOLOGY 32/30 :3374-3382,2014
  • MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer.
    BMC CANCER 14/957 :1-11,2014
  • ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer
    YONSEI MEDICAL JOURNAL 55/6 :1664-1671,2014
  • PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis.
    NATURE COMMUNICATIONS 6/7769 :1-14,2015
  • The Korean guideline for cervical cancer screening
    JOURNAL OF GYNECOLOGIC ONCOLOGY 26/3 :232-239,2015
  • Asian Society of Gynecologic Oncology International Workshop 2014
    JOURNAL OF GYNECOLOGIC ONCOLOGY 26/1 :68-74,2015
  • Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer
    PATHOBIOLOGY 82/5 :203-211,2015
  • Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis.
    ONCOTARGET 6/36 :39088-39097,2015
  • Clinical significance of OCT4 and SOX2 protein expression in cervical cancer
    BMC CANCER 15/ :1,015-1,022,2015
  • Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology
    MEDICINE 95/3 :2,425-2,430,2016
  • Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer
    YONSEI MEDICAL JOURNAL 57/3 :580-587,2016
  • Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer
    ONCOTARGET 7/31 :49,481-49,497,2016
  • Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.
    JOURNAL OF TRANSLATIONAL MEDICINE 14/1 :124-135,2016
  • Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea.
    BMC CANCER 16/5 :12,885-12,892,2016
  • Diagnostic performance and establishment of reference limits of HE4 in Korean healthy women.
    GYNECOLOGIC ONCOLOGY 143/1 :128-134,2016
  • Relationship Between Gonadotropin-Releasing Hormone/Gonadotropin-Releasing Hormone Receptor Signaling and Progesterone Receptors in Human Trophoblasts
    JOURNAL OF REPRODUCTIVE MEDICINE 61/5-6 :275-281,2016
  • Over-expression of BMI1 is associated with favorable prognosis in cervical cancer
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 9/2 :1,849-1,857,2016
  • Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissue
    ONCOTARGET 7/43 :70,524-70,534,2016
  • Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer
    ONCOTARGET 7/47 :77,052-77,070,2016
  • Preoperative Assessment of Lymph Node Metastasis in Endometrial Cancer: A Korean Gynecologic Oncology Group Study
    CANCER 123/2 :263-272,2017
  • API5 confers cancer stem cell-like properties through the FGF2-NANOG axis
    Oncogenesis 6/1 :e285-,2017
  • Association of isolated single umbilical artery with perinatal outcomes: Systemic review and meta-analysis.
    Obstetrics & Gynecology Science 60/3 :266-273,2017
  • Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer
    ANTICANCER RESEARCH 37/9 :4,873-4,879,2017
  • HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells.
    CANCER RESEARCH 77/18 :5,039-5,053,2017
  • API5 induces cisplatin resistance through FGFR signaling in human cancer cells
    EXPERIMENTAL AND MOLECULAR MEDICINE 49/9 :e374-1-e374-10,2017
  • The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis
    BIOMED RESEARCH INTERNATIONAL 2017/- :1-11,2017
  • Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
    LANCET ONCOLOGY 18/9 :1,274-1,283,2017
  • An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)
    CANCER RESEARCH AND TREATMENT 50/1 :195-203,2018
  • Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer.
    GYNECOLOGIC ONCOLOGY 149/2 :381-387,2018
  • Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis
    CANCER RESEARCH 78/10 :2,638-2,653,2018
  • Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-Gene Panels: Beyond BRCA1/2.
    CANCER RESEARCH AND TREATMENT 50/3 :917-925,2018
  • Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models.
    CANCER RESEARCH AND TREATMENT 50/3 :956-963,2018
  • Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer.
    SCIENTIFIC REPORTS 8/1 :12,161-12,172,2018
  • DNA mismatch repair protein immunohistochemistry and MLH1 promotor methylation testing for practical molecular classification and the prediction of prognosis in endometrial cancer
    Cancers 10/9 :279-293,2018
  • Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer
    BRITISH JOURNAL OF CANCER 119/5 :530-537,2018
  • Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance
    JOURNAL OF CLINICAL INVESTIGATION 128/9 :4,098-4,114,2018
  • Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression
    PLOS ONE 13/10 :e0205297-e0205312,2018
  • Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
    Obstetrics & Gynecology Science 61/3 :344-351,2018
  • Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer
    BIOMED RESEARCH INTERNATIONAL 2018/ :1942867-1942876,2018
  • Current Status of Human Papillomavirus Infection and Introduction of Vaccination to the National Immunization Program in Korea: an Overview
    JOURNAL OF KOREAN MEDICAL SCIENCE 33/52 :e331-e347,2018

저서

  • Perspectives in gene expression 2003년 단독저자
  • 실용적 부인종양학 2007년 단독저자
  • 부인과학(제4판) 2007년 공동저자
  • 자궁경부암의 치료 2009년 공동저자
  • 부인과학(제5판) 2015년 공동저자

김재훈

진료철학
2000년부터 4년 동안 미국 하버드부속 브리감&위민스병원(Brigham and Women’s Hospital)에서 부인종양학에 대한 최신 기술과 다양한 형태에 대해 연수하였으며 자궁암 및 난소암의 조기발견을 위한 새로운 진단법 개발을 주제로 설정해 끊임없는 임상연구를 진행하고 있습니다. 환자 치료에 있어 다빈치 로봇 수술기를 활용한 최신 기법을 도입함으로써 정확하면서도 빠른 시간 내에 완벽하게 치료함을 목적으로 삼고 있습니다.

콘텐츠 처음으로 이동

네크워크 링크안내/사이트 정보